These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
601 related articles for article (PubMed ID: 15140937)
1. Retarded axonal transport of R406W mutant tau in transgenic mice with a neurodegenerative tauopathy. Zhang B; Higuchi M; Yoshiyama Y; Ishihara T; Forman MS; Martinez D; Joyce S; Trojanowski JQ; Lee VM J Neurosci; 2004 May; 24(19):4657-67. PubMed ID: 15140937 [TBL] [Abstract][Full Text] [Related]
2. Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform. Ishihara T; Hong M; Zhang B; Nakagawa Y; Lee MK; Trojanowski JQ; Lee VM Neuron; 1999 Nov; 24(3):751-62. PubMed ID: 10595524 [TBL] [Abstract][Full Text] [Related]
3. Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy. Kraemer BC; Zhang B; Leverenz JB; Thomas JH; Trojanowski JQ; Schellenberg GD Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9980-5. PubMed ID: 12872001 [TBL] [Abstract][Full Text] [Related]
4. Tau and axonopathy in neurodegenerative disorders. Higuchi M; Lee VM; Trojanowski JQ Neuromolecular Med; 2002; 2(2):131-50. PubMed ID: 12428808 [TBL] [Abstract][Full Text] [Related]
5. Age-dependent axonal transport and locomotor changes and tau hypophosphorylation in a "P301L" tau knockin mouse. Gilley J; Seereeram A; Ando K; Mosely S; Andrews S; Kerschensteiner M; Misgeld T; Brion JP; Anderton B; Hanger DP; Coleman MP Neurobiol Aging; 2012 Mar; 33(3):621.e1-621.e15. PubMed ID: 21492964 [TBL] [Abstract][Full Text] [Related]
6. Neurodegenerative disorder FTDP-17-related tau intron 10 +16C → T mutation increases tau exon 10 splicing and causes tauopathy in transgenic mice. Umeda T; Yamashita T; Kimura T; Ohnishi K; Takuma H; Ozeki T; Takashima A; Tomiyama T; Mori H Am J Pathol; 2013 Jul; 183(1):211-25. PubMed ID: 23680655 [TBL] [Abstract][Full Text] [Related]
7. Impaired glutamate transport in a mouse model of tau pathology in astrocytes. Dabir DV; Robinson MB; Swanson E; Zhang B; Trojanowski JQ; Lee VM; Forman MS J Neurosci; 2006 Jan; 26(2):644-54. PubMed ID: 16407562 [TBL] [Abstract][Full Text] [Related]
8. Effect of Pin1 or microtubule binding on dephosphorylation of FTDP-17 mutant Tau. Yotsumoto K; Saito T; Asada A; Oikawa T; Kimura T; Uchida C; Ishiguro K; Uchida T; Hasegawa M; Hisanaga SI J Biol Chem; 2009 Jun; 284(25):16840-16847. PubMed ID: 19401603 [TBL] [Abstract][Full Text] [Related]
9. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics. Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011 [TBL] [Abstract][Full Text] [Related]
10. Axonal degeneration induced by targeted expression of mutant human tau in oligodendrocytes of transgenic mice that model glial tauopathies. Higuchi M; Zhang B; Forman MS; Yoshiyama Y; Trojanowski JQ; Lee VM J Neurosci; 2005 Oct; 25(41):9434-43. PubMed ID: 16221853 [TBL] [Abstract][Full Text] [Related]
11. Transgenic mouse model of tauopathies with glial pathology and nervous system degeneration. Higuchi M; Ishihara T; Zhang B; Hong M; Andreadis A; Trojanowski J; Lee VM Neuron; 2002 Aug; 35(3):433-46. PubMed ID: 12165467 [TBL] [Abstract][Full Text] [Related]
12. Analysis of tauopathies with transgenic mice. Hutton M; Lewis J; Dickson D; Yen SH; McGowan E Trends Mol Med; 2001 Oct; 7(10):467-70. PubMed ID: 11597522 [TBL] [Abstract][Full Text] [Related]
13. Early-onset cognitive deficits and axonal transport dysfunction in P301S mutant tau transgenic mice. Onishi T; Matsumoto Y; Hattori M; Obayashi Y; Nakamura K; Yano T; Horiguchi T; Iwashita H Neurosci Res; 2014 Mar; 80():76-85. PubMed ID: 24406748 [TBL] [Abstract][Full Text] [Related]
14. Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau. Tatebayashi Y; Miyasaka T; Chui DH; Akagi T; Mishima K; Iwasaki K; Fujiwara M; Tanemura K; Murayama M; Ishiguro K; Planel E; Sato S; Hashikawa T; Takashima A Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13896-901. PubMed ID: 12368474 [TBL] [Abstract][Full Text] [Related]
15. Distinct FTDP-17 missense mutations in tau produce tau aggregates and other pathological phenotypes in transfected CHO cells. Vogelsberg-Ragaglia V; Bruce J; Richter-Landsberg C; Zhang B; Hong M; Trojanowski JQ; Lee VM Mol Biol Cell; 2000 Dec; 11(12):4093-104. PubMed ID: 11102510 [TBL] [Abstract][Full Text] [Related]
16. Mutant (R406W) human tau is hyperphosphorylated and does not efficiently bind microtubules in a neuronal cortical cell model. Krishnamurthy PK; Johnson GV J Biol Chem; 2004 Feb; 279(9):7893-900. PubMed ID: 14660557 [TBL] [Abstract][Full Text] [Related]
17. Drosophila models of human tauopathies indicate that Tau protein toxicity in vivo is mediated by soluble cytosolic phosphorylated forms of the protein. Feuillette S; Miguel L; Frébourg T; Campion D; Lecourtois M J Neurochem; 2010 May; 113(4):895-903. PubMed ID: 20193038 [TBL] [Abstract][Full Text] [Related]
18. The tau N279K exon 10 splicing mutation recapitulates frontotemporal dementia and parkinsonism linked to chromosome 17 tauopathy in a mouse model. Dawson HN; Cantillana V; Chen L; Vitek MP J Neurosci; 2007 Aug; 27(34):9155-68. PubMed ID: 17715352 [TBL] [Abstract][Full Text] [Related]
19. Amyotrophic lateral sclerosis/parkinsonism dementia complex: transgenic mice provide insights into mechanisms underlying a common tauopathy in an ethnic minority on Guam. Trojanowski JQ; Ishihara T; Higuchi M; Yoshiyama Y; Hong M; Zhang B; Forman MS; Zhukareva V; Lee VM Exp Neurol; 2002 Jul; 176(1):1-11. PubMed ID: 12093078 [TBL] [Abstract][Full Text] [Related]
20. Tau protein in familial and sporadic diseases. Yancopoulou D; Spillantini MG Neuromolecular Med; 2003; 4(1-2):37-48. PubMed ID: 14528051 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]